Skip to content

Safety evaluation of an excessive consumption of a food containing botanical extract - Placebo control double blind parallel group comparison clinical trial -

Safety evaluation of an excessive consumption of a food containing botanical extract - Placebo control double blind parallel group comparison clinical trial - - Safety evaluation of an excessive consumption of a food containing botanical extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030591
Enrollment
52
Registered
2018-01-05
Start date
2018-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

Study food 5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks Control food 5 times of serving size per day for 4 weeks, safety evaluations are p

Sponsors

Maruzen Pharmaceuticals Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy males and females who equal to or more than 20 years and less than 65 years of age 2.Subjects who can visit the medical institution at the scheduled visit date 3. Subjects who are able to understand the study and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects who systolic blood pressure is less than 90 mmHg 2. Subjects who equal to or more than 25kg/m of BMI 3. Subjects who given surgery, or taken medication due to serious illness within a month 4. Subject who present heart, liver, kidney disorders 5. Subjects who are taking drugs, foods for specified health use or functional foods which could affect this study 6. Subjects who Females in pregnancy, lactation and scheduled pregnancy period 7 Subjects who with heavy use of alcohol, and heavy smoking 8. Subject who have been felt ill by blood collection 9. Subjects who donated 200 ml or more of blood within a month prior to the study 10 Subjects who with irregular eating habits(Night shift worker) 11. Subjects who plan business trip or trip for 10 consecutive days or more 12. Subjects who have allergy related to the test foods 13. Subjects who have chronic diarrhea or chronic coprostasis 14.Subjects who already participating in other clinical trials, or planning to participate during this examination period 15. Subjects who can not agree with prliminary explanation 16. Subjects who are deemed to be unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
< Safety> Side effect incidence, Adverse event incidence, clinical examination items, physiological examination items

Countries

Japan

Contacts

Public ContactEndoh Yoshiki

New drug research center, Inc. Clinical Research Dept.

y-endoh@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026